triple-hormone-receptor agonist retatrutide for obesity - a phase 2 trial ⭐️topline results from TRIUMPH-1, 3 clinical evaluating #retatrutide, an investigational GIP / GLP-1 / glucagon triple hormone receptor agonist, in adults with or “overweight” Original Article: Triple–Hormone-Receptor Agonist Retatrutide
Pay in 4 interest-free payments of $7.30 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2



















![[SIGNED] JBJ95 - SPARK (WHITE VER.) Hyungwon Magazine](https://cdn.shopify.com/s/files/1/0665/3054/1820/files/IMG_8983.heic?v=1695593589)

